The Mark Hughes Foundation (MHF) is a Non-Profit, Health Promotion Charity formed in Newcastle by Mark and Kirralee Hughes following Mark's diagnosis with Brain Cancer in 2013. The Mark Hughes Foundation's mission is to raise much-needed funds for research, to create awareness, and support brain cancer patients and their families. MHF host an annual Brian Cancer Patient forum in Newcastle as well as fund five Brain Care Coordinators in the Hunter New England and Mid North Coast Health districts.
MHF Funded support recourses include:
The CarerWell website and program has been created by mental health professionals and researchers from the University of Newcastle and the Hunter Medical Research Institute (HMRI), with the support of an Innovation Grant from the Mark Hughes Foundation. CarerWell is for anyone supporting and helping someone with brain cancer. It is also for those who are caring for a friend or family member who may not be a close loved one. While various terms are used throughout the website and program, CarerWell recognises that each situation is unique.
The MHF Patient Pack is a symbol of hope, comfort and care for those diagnosed with brain cancer and their families. Each pack includes the Survivorship Diary, the Survivalist companion, meaningful MHF items, and valuable information to help patients navigate every stage of their journey with primary brain cancer.
We encourage all primary brain cancer patients or their carers to order this new invaluable resource via the MHF website.
The Survivorship Diary is a free resource for brain cancer patients and their families — designed for patients, by a patient. Reimagined and expanded, the resource is now two separate books. The diary combines practical daily support with the compassion and insight of someone who has lived the experience. Inside, you’ll find dedicated sections to record your medical team, treatment schedules, appointments, and questions. To accompany the Survivorship Diary, is the Survivalist — a comprehensive guide written with the insight of a patient and enriched by contributions from medical oncology teams, brain cancer care coordinators, surgical teams, researchers, carers, and families alike